Gastrin-Releasing Peptide
"Gastrin-Releasing Peptide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neuropeptide and gut hormone that helps regulate GASTRIC ACID secretion and motor function. Once released from nerves in the antrum of the STOMACH, the neuropeptide stimulates release of GASTRIN from the GASTRIN-SECRETING CELLS.
| Descriptor ID |
D019886
|
| MeSH Number(s) |
D06.472.317.410 D12.644.400.315 D12.776.631.650.315
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Gastrin-Releasing Peptide".
Below are MeSH descriptors whose meaning is more specific than "Gastrin-Releasing Peptide".
This graph shows the total number of publications written about "Gastrin-Releasing Peptide" by people in this website by year, and whether "Gastrin-Releasing Peptide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gastrin-Releasing Peptide" by people in Profiles.
-
Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer. Clin Cancer Res. 1999 Nov; 5(11):3385-93.
-
Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Invest. 1996 Feb 01; 97(3):806-13.
-
Initiators and promoters of lung cancer. Chest. 1993 Jan; 103(1 Suppl):4S-11S.
-
Preclinical evaluation of an anti-autocrine growth factor monoclonal antibody for treatment of patients with small-cell lung cancer. J Natl Cancer Inst. 1991 Oct 16; 83(20):1470-6.
-
Autocrine growth factors as therapeutic targets in lung cancer. Chest. 1989 Jul; 96(1 Suppl):31S-34S.
-
Consideration of the chemistry of solid-phase matrix interaction leads to improved quantitation of neuropeptides. Ann N Y Acad Sci. 1988; 547:41-53.
-
Gastrin-releasing peptide and other autocrine growth factors in lung cancer: pathogenetic and treatment implications. Important Adv Oncol. 1988; 55-64.